According to Stratistics MRC,the Global Cell Banking Outsourcing Market is accounted for $3.2 billion in 2016 and expected to grow at a CAGR of 20.0% to reach $11.87 billion by 2023.
Gaithersburg, Maryland, United States – January 3, 2018 —
Factors such as tissues required for R&D, cells for the regenerative medicine production, demand for stem cell therapies, increasing number of cord blood banks, development of sophisticated preservation technologies, demand for monoclonal antibodies, increasing prevalence of cancer, demand for ready-to-use bioassay banks are augmenting the market growth. Regenerative medicine, tissue engineering and gene therapy offer the opportunity for curing, number of elderly patients has also significantly increased, and recently adipose tissue banking has become available and offers opportunity to store stem cells for future use. These are the few trends observed by the market. However, ethical concerns related to stem cell research, high cost of therapies, risk of contamination of cell lines by manual errors or environmental conditions are impeding the market growth.
Request for sample here: http://www.strategymrc.com/report/cell-banking-outsourcing-market-2017/request-sample
Based on Cell Type, for Stem Cell Banking there is no scientific evidence to substantiate clinical benefits with the use of stem cells derived from cord tissue, placenta, tooth extract etc,. Yet, procurement and banking of these biological is increasingly becoming a commercial activity. For example, use of Umbilical Cord Blood (UCB) derived HSCs for treatment of various haematological and immunological disorders is currently well established. Cord blood stored in private banks is used for either autologous or allogeneic transplants. However, few challenges like regulatory issues, licensure, have increased the cost to bank and some obstetrical practices have been observed.
Access the complete report at: http://www.strategymrc.com/report/cell-banking-outsourcing-market-2017
Based on Bank Master cell bank represents a cell reserve “frozen-in-time”. It prevents contamination and deterioration. The Master cell bank is used for ensuring a stock of cells to avoid genetic variation within the cell culture. Biosafety testing and characterization methods include sterility and mycoplasma testing, C01 Barcode assay, in vitro and in vivo assays for adventitious viral contaminants, reverse transcription assays, transmission electron microscopy, PCR and qPCR assays, bovine and porcine virus assays, and retroviral infectivity assays.
North America accounted for the largest share due to high number of research and development projects and growing need for vaccines. Asia Pacific is anticipated to witness significant growth owing to investments in biotechnology sector, R&D activities for cancer treatment and fertility preservation.
Some of the key players in Global Cell Banking Outsourcing Market market are SGS Life Sciences, Reliance Life Sciences, PX’Therapeutics SA, Lonza, LifeCell International Pvt. Ltd., Goodwin Biotechnology Inc., GlobalStem Inc., Cryo-Cell International Inc., Wuxi Apptec, Tran-Scell Biologics Pvt. Ltd., Toxikon Corporation, Texcell, Cryobanks International India, Covance and CordLife.
Make an inquiry at: http://www.strategymrc.com/report/cell-banking-outsourcing-market-2017
• Viral Cell Banking
• Master Cell Banking
• Working Cell Banking
• Bank Characterization and Testing
• Cell Bank Storage
• Cell Bank Preparation
Cell Types Covered:
• Non-Stem Cell Banking
• Stem Cell Banking
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
Follow us on Twitter: https://twitter.com/StratisticsMRC
Follow us on LinkedIn at: https://www.linkedin.com/company/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile
About Stratistics MRC
We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends.
Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.
Name: James Lamb
Email: Send Email
Organization: Stratistics Market Research Consulting Pvt Ltd
This content is produced independently of Reuters Editorial News. For content inquiry, please contact [email protected]